Intermediate Uveitis

  • Suchitra Pradeep
  • Jyotirmay Biswas


Intermediate uveitis (IU) is an anatomical diagnosis characterized by ocular inflammation localized in the anterior vitreous and the vitreous base overlying the ciliary body and peripheral retina which is otherwise called pars plana [1].


Human Leukocyte Antigen Retinal Detachment Lyme Disease Macular Hole Ciliary Body 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Vitale AT, Zierhut M, Foster CS. Intermediate uveitis. In: Foster CS, Vitale AT, editors. Diagnosis and treatment of uveitis. Philadelphia: W.B.Saunders and Company; 2002. p. 844–57.Google Scholar
  2. 2.
    Hogan MJ, Kimura SJ, O’Connor GR, et al. Peripheral retinitis and chronic cyclitis in children. Trans Ophthalmol Soc UK. 1965;85:39–52.PubMedGoogle Scholar
  3. 3.
    Schepens CL. L’inflammation de la region de I’ora serrata et ses sequelles. Bull Soc Ophtha. 1950;73:113–24.Google Scholar
  4. 4.
    Welch RB, Maumenee AE, Wahlen HE. Peripheral posterior segment inflammation, vitreous opacities, and edema of the posterior pole. Arch Ophthalmol. 1960;64:540–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Bloch-Michel E, Nussenblatt RB. International Uveitis study group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol. 1987;103:234–5.CrossRefPubMedGoogle Scholar
  6. 6.
    Jabs DA, Nusenblatt RB, Rosenbaum JT. Standardization of Uveitis nomenclature (SUN) working group. Standardization of uveitis nomenclature for reporting clinical data results of the First International Workshop. Am J Ophthalmol. 2005;140:509–16.CrossRefPubMedGoogle Scholar
  7. 7.
    Chang JH, Wakefield D. Uveitis: a global perspective. Ocul Immunol Inflamm. 2002;10(4):263–79.CrossRefPubMedGoogle Scholar
  8. 8.
    Yang P, Zhang Z, Zhou H, et al. Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in china. Curr Eye Res. 2005;30(11):943–8.CrossRefPubMedGoogle Scholar
  9. 9.
    Wakabayashi T, Morimura Y, Miyamoto Y, et al. Changing patterns of intraocular inflammatory disease in Japan. Ocul Immunol Inflamm. 2003;11(4):277–86.CrossRefPubMedGoogle Scholar
  10. 10.
    Khairallah M, Yahia SB, Ladjimi A, et al. Pattern of uveitis in a referral centre in Tunisia. N Afr Eye. 2007;21(1):33–9.CrossRefGoogle Scholar
  11. 11.
    Oruc S, Kaplan AD, Galen M, et al. Uveitis referral pattern in a midwest university eye center. Ocul Immunol Inflamm. 2003;11(4):287–98.CrossRefPubMedGoogle Scholar
  12. 12.
    Biswas J, Narain S, Das D, Ganesh SK. Patterns of uveitis in a referral unit in India. Int Ophthalmol. 1996–1997;20:223–8Google Scholar
  13. 13.
    McCannel CA, Holland GN, Helm CJ, Winston JV, Rimmer TG. Causes of uveitis in the general practice of ophthalmology. UCLA community based Uveitis study group. Am J Ophthalmol. 1996;121:35–46.CrossRefPubMedGoogle Scholar
  14. 14.
    Chan SM, Hudson M, Weis E. Anterior and intermediate cases referred to a tertiary care center in Alberta. Can J Ophthalmol. 2007;42:860–4.CrossRefPubMedGoogle Scholar
  15. 15.
    Henderly DE, Genstler AJ, Smith RE, Rao NA. Changing patterns of uveitis. Am J Ophthalmol. 1987;103:131–6.CrossRefPubMedGoogle Scholar
  16. 16.
    Rodriguez A, Calonge M, Pedroza-Seres M, Akova YA, Messmer EM, D’Amico DJ, et al. Referral patterns of uveitis in a tertiary eye care centre. Arch Ophthalmol. 1996;114:593–9.CrossRefPubMedGoogle Scholar
  17. 17.
    Singh R, Gupta V, Gupta A. Pattern of uveitis in a referral clinic in North India. Indian J Ophthalmol. 2004;52:121–5.PubMedGoogle Scholar
  18. 18.
    Biswas J, Narain S, Das D, Ganesh SK. Patt erns of uveitis in a referral unit in India. Int Ophthalmol. 1996–1997;20:223–8.Google Scholar
  19. 19.
    Rathinam SR, Namperumalsamy P. Global variation and pattern changes in epidemiology of uveitis. Indian J Ophthalmol. 2007;55:173–83.CrossRefPubMedGoogle Scholar
  20. 20.
    Vadot E. Epidemiology of IU- A prospective study in Savoy. Dev Ophthalmol. 1992;23:33–4.CrossRefPubMedGoogle Scholar
  21. 21.
    Dandona L, Dandona R, John RK, McCarty CA, Rao GN. Population based assessment of uveitis in an urban population in Southern India. Br J Ophthalmol. 2000;84:706–9.PubMedCentralCrossRefPubMedGoogle Scholar
  22. 22.
    Thorne JE, Daniel A, Jabs DA, Kedhar SR, Peters GB, Dunn JP. Smoking as a risk factor for cystoid macular edema complicating intermediate uveitis. Am J Ophthalmol. 2008;145:841–6.PubMedCentralCrossRefPubMedGoogle Scholar
  23. 23.
    Engelmann K, Ness T, Greiner K, Hudde T. Uveitis intermedia in childhood. Klin Monatsbl Augenheilkd. 2007;224:462–8.CrossRefPubMedGoogle Scholar
  24. 24.
    Biswas J, Raghavendran SR, Vijaya R. Intermediate uveitis of pars planitis type in identical twins. Report of a case. Int Ophthalmol. 1998;22:275–7.CrossRefPubMedGoogle Scholar
  25. 25.
    Fitt A, Harrison RJ. Familial intermediate uveitis: a case report of two brothers. Eye. 1999;13:808–9.CrossRefPubMedGoogle Scholar
  26. 26.
    Lee AG. Familial pars planitis. Ophthalmic Genet. 1995;16:17–9.CrossRefPubMedGoogle Scholar
  27. 27.
    Tejada P, Sanz A, Criado D. Pars planitis in a family. Int Ophthalmol. 1994;18:111–3.CrossRefPubMedGoogle Scholar
  28. 28.
    Browning AC, Calladine D, Collins N, Harmer AW, Amoaku WM. HLA typing of a Hong Kong Chinese family with intermediate uveitis. Br J Ophthalmol. 2006;90:657.PubMedCentralCrossRefPubMedGoogle Scholar
  29. 29.
    Tang WM, Pulido JS, Eckels DD, Han DP, Mieler WF, Pierce K. The association of HLA-DR15 and intermediate uveitis. Am J Ophthalmol. 1997;123:70–5.CrossRefPubMedGoogle Scholar
  30. 30.
    Pederson JE, Kenyon KR, Green WR, et al. Pathology of pars planitis. Am J Ophthalmol. 1978;86:762–74.CrossRefPubMedGoogle Scholar
  31. 31.
    Opremack EM, Cowans AB, Orosz CG. Enumeration of autoreactive helper T lymphocytes in uveitis. Invest Ophthalmol Vis Sci. 1991;32:2561–7.Google Scholar
  32. 32.
    Wetzig RP, Chan CC, Nusenblatt RB. Clinical and immunological studies of parsplanitis in a family. Br J Ophthalmol. 1998;72:5–10.CrossRefGoogle Scholar
  33. 33.
    Nölle B, Eckardt C. Cellular phenotype of vitreous cells in intermediate uveitis. Dev Ophthalmol. 1992;23:145–9.CrossRefPubMedGoogle Scholar
  34. 34.
    Boyd SR, Young S, Lightman S. Immunopathology of noninfectious posterior and intermediate uveitides. Surv Ophthalmol. 2001;46:209–33.CrossRefPubMedGoogle Scholar
  35. 35.
    Nusenblatt RB, Palestine AG. Intermediate uveitis. In: Uveitis: fundamentals and clinical practice. Chicago: Yearbook Medical; 1989. p. 279–88.Google Scholar
  36. 36.
    Felder KS, Brockhurst RJ. Neovascular fundus abnormalities and peripheral uveitis. Arch Ophthalmol. 1982;100:750–4.CrossRefPubMedGoogle Scholar
  37. 37.
    Smith RE, Godfrey WA, Kimura SJ. Complications of chronic cyclitis. Am J Ophthalmol. 1976;82:277–82.CrossRefPubMedGoogle Scholar
  38. 38.
    Herbert HM, Viswanathan A, Jackson H, Lightman SL. Risk factors for elevated intraocular pressure in uveitis. J Glaucoma. 2004;13:96–9.CrossRefPubMedGoogle Scholar
  39. 39.
    Malinowski SM, Pulido JS, Folk JC. Long term visual outcome and complications associated with pars planitis. Ophthalmology. 1993;100:818–24.CrossRefPubMedGoogle Scholar
  40. 40.
    Donaldson MJ, Pulido JS, Herman DC, Diehl N, Hodge D. Pars planitis: a 20-year study of incidence, clinical features, and outcomes. Am J Ophthalmol. 2007;144:812.7.CrossRefGoogle Scholar
  41. 41.
    Felder KS, Brockhurst RJ. Neovascular fundus abnormalities in peripheral uveitis. Arch Ophthalmol. 1982;100:750–4.CrossRefPubMedGoogle Scholar
  42. 42.
    Lauer AK, Smith JR, Robertson JE, et al. Vitreous hemorrhage is a common complication of pediatric pars planitis. Ophthalmology. 2002;109:95–8.CrossRefPubMedGoogle Scholar
  43. 43.
    Valentincic NV, Kraut A, Rothova A. Vitreous hemorrhage in multiple sclerosis-associated uveitis. Ocul Immunol Inflamm. 2007;15:19–25.CrossRefPubMedGoogle Scholar
  44. 44.
    Brockhurst RJ, Schepens CL. Peripheral uveitis. The complication of retinal detachment. Arch Ophthalmol. 1968;80:747.CrossRefPubMedGoogle Scholar
  45. 45.
    Deane JS, Rosenthal AR. Course and complications of intermediate uveitis. Acta Ophthalmol Scand. 1997;75:82–4.CrossRefPubMedGoogle Scholar
  46. 46.
    Poindron V, Camuset G, Krencker D, et al. Intermediate uveitis, an ophthalmological manifestation of systemic disease. J Fr Ophtalmol. 2013;36(4):331–5.CrossRefPubMedGoogle Scholar
  47. 47.
    Bonfioli AA, Damico FM, Curi AL, Orefice F. Intermediate uveitis. Semin Ophthalmol. 2005;20(3):147–54.CrossRefPubMedGoogle Scholar
  48. 48.
    Sudharshan S, Ganesh SK, Balu G, Mahalakshmi B, Therese LK, Madhavan HN, Biswas J. Utility of QuantiFERON®-TB Gold test in diagnosis and management of suspected tubercular uveitis in India. Int Ophthalmol. 2012;32(3):217–23.CrossRefPubMedGoogle Scholar
  49. 49.
    Ganesh SK, Roopleen, Biswas J, Veena N. Role of high resolution computerized tomography (HRCT) of the chest in granulomatous uveitis: a tertiary uveitis clinic experience from India. Ocul Immunol Inflamm. 2011;19(1):51–7.CrossRefPubMedGoogle Scholar
  50. 50.
    Prieto JF, Dios E, Gutierrez JM, Mayo A, Calonge M, Herreras JM. Pars planitis: epidemiology, treatment, and association with multiple sclerosis. Ocul Immunol Inflamm. 2001;9:93–102.CrossRefPubMedGoogle Scholar
  51. 51.
    Gürlü VP, Alimgil ML, Esgin H. Fluorescein angiographic findings in cases with intermediate uveitis in the inactive phase. Can J Ophthalmol. 2007;42(1):107–9.CrossRefPubMedGoogle Scholar
  52. 52.
    Pruett RC, Brockhurst J, Letts NF. Fluorescein angiography of peripheral uveitis. Am J Ophthalmol. 1974;77:448–53.CrossRefPubMedGoogle Scholar
  53. 53.
    Ossewaarde-van Norel J, Camfferman LP, Rothova A. Discrepancies between fluorescein angiography and optical coherence tomography in macular edema in uveitis. Am J Ophthalmol. 2012;154(2):233–9.CrossRefPubMedGoogle Scholar
  54. 54.
    Domalpally A, Altaweel MM, Kempen JH, et al. Optical coherence tomography evaluation in the Multicenter Uveitis Steroid Treatment (MUST) trial. Ocul Immunol Inflamm. 2012;20(6):443–7.CrossRefPubMedGoogle Scholar
  55. 55.
    Doro D, Manfrè A, Deligianni V, Secchi AG. Combined 50- and 20-MHz frequency ultrasound imaging in intermediate uveitis. Am J Ophthalmol. 2006;141(5):953–5.CrossRefPubMedGoogle Scholar
  56. 56.
    Tran VT, LeHoang P, Herbort CP. Value of high-frequency ultrasound biomicroscopy in uveitis. Eye (Lond). 2001;15:23–30.CrossRefGoogle Scholar
  57. 57.
    Scott AW, Mruthyunjaya P, McCallum RM, Jaffe GJ. Diagnostic yield of vitreous biopsy in presumed sarcoidosis-related posterior segment inflammation. Graefes Arch Clin Exp Ophthalmol. 2012;250(9):1379–85.CrossRefPubMedGoogle Scholar
  58. 58.
    Kok H, Lau C, Maycock N, et al. Outcome of intravitreal triamcinolone in uveitis. Ophthalmology. 2005;112:1916–21. A large interventional case series demonstrating the unpredictability of corticosteroid- induced IOP rises.CrossRefPubMedGoogle Scholar
  59. 59.
    Androudi S, Letko E, Meniconi M, et al. Safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema. Ocul Immunol Inflamm. 2005;13:205–12.CrossRefPubMedGoogle Scholar
  60. 60.
    Vanrell RH, Cardillo JA, Kuppermann BD. Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema. Clinical Ophthalmol. 2011;5:139–46.Google Scholar
  61. 61.
    Mackensen F, Heinz C, Becker MD, et al. Intravitreal bevacizumab (avastin) as a treatment for refractory macular edema in patients with uveitis. Retina. 2008;28:41–5.CrossRefPubMedGoogle Scholar
  62. 62.
    Galor A, Jabs DA, Leder HA, et al. Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation. Ophthalmology. 2008;115(10):1826–32.CrossRefPubMedGoogle Scholar
  63. 63.
    Doycheva D, Deuter C, Stuebiger, et al. Mycophenolate mofetil in the treatment of uveitis in children. Br J Ophthalmol. 2007;91(2):180–4.PubMedCentralCrossRefPubMedGoogle Scholar
  64. 64.
    Kruh JN, Yang P, Suelves AM, Foster CS. Infliximab for the treatment of refractory noninfectious uveitis: a study of 88 patients with long-term follow-up. Ophthalmology. 2013;121(1):358–64. pii: S0161-6420(13)00619-2.CrossRefPubMedGoogle Scholar
  65. 65.
    Ganesh SK, Babu K, Biswas J. Phacoemulsification with intraocular lens implantation in cases of pars planitis. J Cataract Refract Surg. 2004;30(10):2072–6.Google Scholar
  66. 66.
    Becker M, Davis JL. Vitrectomy in the treatment of uveitis. Am J Ophthalmol. 2005;140:1096–105.CrossRefPubMedGoogle Scholar
  67. 67.
    Kaplan HJ. Intermediate uveitis (pars planitis, chronic cyclitis): a four-step approach to treatment. In: Saari KM, editor. Uveitis Update. Amsterdam: Experta Medica; 1984. p. 169–72.Google Scholar
  68. 68.
    Brockhurst RJ, Schepens CL, Okamura ID. Uveitis. II. Peripheral uveitis: clinical description, complications and differential diagnosis. Am J Ophthalmol. 1960;49:1257–66.CrossRefPubMedGoogle Scholar
  69. 69.
    Tsai JH, Rao NA. Pars planitis and other intermediate uveitis. In: Yanoff M, Duker JS. Ophthalmology. 3rd ed. Philadelphia: Mosby; 2008:964–9.Google Scholar

Copyright information

© Springer India 2016

Authors and Affiliations

  1. 1.Department of UveaSankara NethralayaChennaiIndia
  2. 2.Sankara NethralayaPondicherryIndia

Personalised recommendations